Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-23T07:34:38.931Z Has data issue: false hasContentIssue false
  • English
  • Français

Antipsychotic medication for women with schizophrenia spectrum disorders – CORRIGENDUM

Published online by Cambridge University Press:  10 May 2023

Bodyl A. Brand ,
Yudith R. A. Haveman ,
Franciska de Beer ,
Janna N. de Boer ,
Paola Dazzan  and
Iris E. C. Sommer
Bodyl A. Brand
Affiliation:
Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Yudith R. A. Haveman
Affiliation:
Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Franciska de Beer
Affiliation:
Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Janna N. de Boer
Affiliation:
Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
Paola Dazzan
Affiliation:
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK
Iris E. C. Sommer
Affiliation:
Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neurosciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
Psychological Medicine , Volume 53 , Issue 10 , July 2023 , pp. 4832
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press

When this article was originally published in Psychological Medicine it included the sentence ‘'Women's stomachs are on average less acidic compared to men's and this increases the absorption of antipsychotic drugs’. Based on the available literature on this topic, it is difficult to determine whether, and to what extent, sex differences in stomach acidity influence the absorption of antipsychotics. Due to this, this sentence has been removed and Figure 1 has been updated to reflect this change.

The authors apologise for this error.

References

Brand, B., Haveman, Y., De Beer, F., De Boer, J., Dazzan, P., & Sommer, I. (2022). Antipsychotic medication for women with schizophrenia spectrum disorders. Psychological Medicine, 52(4), 649–663. doi:10.1017/S0033291721004591CrossRefGoogle ScholarPubMed